What Happens When an IPO Goes Wrong?

What Happens When an IPO Goes Wrong? Play

Aug. 13 (Bloomberg) -- Vascular Biogenics, the Israeli biotechnology company that went public in the U.S. last month, canceled the initial public offering after a “substantial” investor failed to pay for the shares it agreed to buy, according to a statement Aug. 8. Bloomberg’s Leslie Picker reports on “Market Makers.” (Source: Bloomberg)

  • On Air Now

    Charlie Rose Watch Now

  • Next

    With All Due Respect

blog comments powered by Disqus